Interleukin-2 as anticancer immunotherapy in the age of checkpoint inhibition

被引：1
|
作者：
Garbe, Claus [1 ]
机构：
[1] Eberhard Karls Univ Tubingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
D O I：
10.21037/tcr.2016.07.02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S313 / S314
页数：2
相关论文
共 50 条
  • [21] POTENTIATION OF INTERLEUKIN-2 RELEASE BY ANTICANCER DRUGS
    TURK, JL
    ABDULHAMIED, TA
    PARKER, D
    AGENTS AND ACTIONS, 1989, 26 (1-2): : 156 - 157
  • [22] THE MULTICHAIN INTERLEUKIN-2 RECEPTOR - A TARGET FOR IMMUNOTHERAPY
    WALDMANN, TA
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 309 - 309
  • [23] INTERLEUKIN-2 IMMUNOTHERAPY, A BIOLOGICAL RESPONSE MODIFIER
    HEMSTREET, GP
    SCHAUB, LB
    WHITEHEAD, RP
    LOUDON, WG
    BRADLEY, EC
    JOURNAL OF UROLOGY, 1986, 135 (04): : A305 - A305
  • [24] RESOLUTION OF WARTS DURING INTERLEUKIN-2 IMMUNOTHERAPY
    ADES, EW
    GILLESPIE, T
    PATHOBIOLOGY, 1990, 58 (02) : 88 - 88
  • [25] THE MULTICHAIN INTERLEUKIN-2 RECEPTOR - A TARGET FOR IMMUNOTHERAPY
    WALDMANN, TA
    PASTAN, IH
    GANSOW, OA
    JUNGHANS, RP
    ANNALS OF INTERNAL MEDICINE, 1992, 116 (02) : 148 - 160
  • [26] INTERLEUKIN-2 - CLINICIAN QUESTION ADOPTIVE IMMUNOTHERAPY
    KLAUSNER, A
    BIO-TECHNOLOGY, 1986, 4 (12): : 1044 - 1044
  • [27] IMMUNOTHERAPY WITH INTERLEUKIN-2 AFTER ABMT IN AML
    HAMON, MD
    PRENTICE, HG
    GOTTLIEB, DJ
    MACDONALD, ID
    CUNNINGHAM, JM
    SMITH, OP
    GILMORE, M
    GANDHI, L
    COLLIS, C
    BONE MARROW TRANSPLANTATION, 1993, 11 (05) : 399 - 401
  • [28] LOCAL AND REGIONAL IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2
    BUBENIK, J
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (01) : 1 - 7
  • [29] The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapy
    Koppenhagen, FJ
    Balemans, LTM
    Steerenberg, PA
    Jagmont, TM
    Den Otter, W
    Storm, G
    JOURNAL OF LIPOSOME RESEARCH, 1999, 9 (03) : 313 - 329
  • [30] INHIBITION OF LYMPHOCYTE MOTILITY BY INTERLEUKIN-2
    HOON, DSB
    WEN, DR
    STENE, M
    GUPTA, RK
    COCHRAN, AJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1986, 66 (03): : 566 - 573
12345